T2 Biosystems Plans 2012 510(k) Filing For First Rapid Candida Test
This article was originally published in The Gray Sheet
Executive Summary
T2 Biosystems will launch a pivotal trial in the first half of 2012 for a rapid molecular diagnostic test for Candida, a fungus often acquired by patients during hospital stays that can cause blood stream infections and sepsis.